TG Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
TGTX Nasdaq 2836 www.tgtherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for TG Therapeutics, Inc.

TG Therapeutics to Host Conference Call on Second Quarter 2026 Financial Results and Business Update - Jul 29th, 2026 5:30 am
Earnings Preview: Amgen (AMGN) Q2 Earnings Expected to Decline - Jul 28th, 2026 8:00 am
TG Therapeutics (TGTX) to Report Q2 Results: Wall Street Expects Earnings Growth - Jul 27th, 2026 8:00 am
How Roche Unexpectedly Buoyed IBD Stock Of The Day TG Therapeutics - Jul 24th, 2026 3:15 pm
TG Therapeutics (TGTX) Gains as Its Key Drug Exceeded Expectations - Jul 13th, 2026 7:47 am
TG Therapeutics (TGTX) Starts Phase 2 Briumvi Trial - Jul 9th, 2026 4:40 am
TG Therapeutics (TGTX) Stock May Still Be Cheap Despite New Trial News - Jul 8th, 2026 10:36 pm
2 Fast-Growing Pharmaceutical Stocks to Buy Now - Jul 8th, 2026 6:25 pm
Can TG Therapeutics' (TGTX) Schizophrenia Trial Meaningfully Redefine BRIUMVI’s Role Beyond Multiple Sclerosis? - Jul 8th, 2026 3:15 pm
Is TG Therapeutics (TGTX) Fully Valued Following Its Schizophrenia Trial Update? - Jul 8th, 2026 10:17 am
TGTX Stock Rises On Wall Street Price Target Hike, New Schizophrenia Trial Launch - Jul 7th, 2026 2:13 pm
Moderna, TG Therapeutics, Agios Pharmaceuticals Q2 Results May Face Increased Scrutiny, BofA Says - Jul 7th, 2026 9:04 am
TG Therapeutics Begins Phase II Study With Briumvi in Schizophrenia - Jul 7th, 2026 6:58 am
TG Therapeutics Announces Initiation of Phase 2 Trial Evaluating BRIUMVI in Patients with Treatment-Resistant Schizophrenia - Jul 6th, 2026 5:30 am
Will Briumvi's Strength Continue to Aid TGTX's Top Line in Q2? - Jul 3rd, 2026 6:31 am
Is TG Therapeutics, Inc. (TGTX) A Good Stock To Buy Now? - Jun 19th, 2026 10:22 am
Immunovant (IMVT) Up 3.6% Since Last Earnings Report: Can It Continue? - Jun 19th, 2026 9:30 am
TG Therapeutics Stock Is On A Hot Streak: Why It's Up 79% And Climbing - Jun 18th, 2026 2:10 pm
TGTX Stock Continues Rally For 8 Straight Sessions On New BRIUMVI Clinical Data - Jun 17th, 2026 3:26 pm
Dow Jones Futures Signal Market Bounce, But Then What? Oracle Dives, SpaceX IPO On Launch Pad - Jun 11th, 2026 6:10 am